COVID-19 Gavi Covax AMC Since 2001, the Netherlands supports Gavi, the vaccine alliance, through project 27598. Gavi is an international organization that was created in 2000 to improve access to new and underused vaccines for children living in the world’s poorest countries. Based in Geneva, Switzerland, Gavi brings together public and private sectors with the shared goal of creating equal access to vaccines for children, wherever they live. In April 2020, the World Health Organization (WHO) hosted the launch of the Access to COVID-19 Tools (ACT) Accelerator, a new global collaboration to accelerate development, production, and equitable access to COVID-19 diagnostics, therapeutics, and vaccines. Gavi, the vaccine alliance together with CEPI and WHO leads the “vaccine pillar” of ACT. Under this pillar, the COVID-19 Global Vaccine Access Facility (Covax Facility) and the Gavi Advance Market Commitment for COVID-19 Vaccines (Gavi Covax AMC) were established. COVAX was the necessary and astonishing response at a time of a worldwide crisis. It brought together partners to spur COVID-19 vaccines procurement and distribution for 92 LMICs. COVAX, was successful in shipping more than 1.88 billion COVID-19 vaccine doses to 146 countries and territories. In 2021 it almost met its target of delivering 950 million doses to 92 lower-income countries, which resulted in a 53% coverage in adult populations. Across 69 AMC countries reporting, 82% of health care workers were vaccinated. In total USD 12,4 billion dollar was mobilized for COVAX between 2020-2022.